产品
编 号：F741191
产品类型
规格
价格
是否有货
1mg
询价
询价
结构图
CAS No: 1407495-02-6
产品详情
生物活性：
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia.
体内研究：
Bococizumab (0-100 mg/kg, i.v.) decreases maternal and fetal cholesterol and does not affect rat embryo-fetal development.Animal Model:Pregnant Sprague-Dawley (SD) rats
Dosage:0, 10, 30, and 100 mg/kg
Administration:Intravenous injection (i.v.)
Result:Decreased in fetal cholesterol levels.Showed well tolerance and no effects on ovarian or uterine parameters.
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia.
体内研究：
Bococizumab (0-100 mg/kg, i.v.) decreases maternal and fetal cholesterol and does not affect rat embryo-fetal development.Animal Model:Pregnant Sprague-Dawley (SD) rats
Dosage:0, 10, 30, and 100 mg/kg
Administration:Intravenous injection (i.v.)
Result:Decreased in fetal cholesterol levels.Showed well tolerance and no effects on ovarian or uterine parameters.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备